Acute renal metabolic effect of metformin assessed with hyperpolarised MRI in rats
- PMID: 28936623
- DOI: 10.1007/s00125-017-4445-6
Acute renal metabolic effect of metformin assessed with hyperpolarised MRI in rats
Abstract
Aims/hypothesis: Metformin inhibits hepatic mitochondrial glycerol phosphate dehydrogenase, thereby increasing cytosolic lactate and suppressing gluconeogenesis flux in the liver. This inhibition alters cytosolic and mitochondrial reduction-oxidation (redox) potential, which has been reported to protect organ function in several disease states including diabetes. In this study, we investigated the acute metabolic and functional changes induced by metformin in the kidneys of both healthy and insulinopenic Wistar rats used as a model of diabetes.
Methods: Diabetes was induced by intravenous injection of streptozotocin, and kidney metabolism in healthy and diabetic animals was investigated 4 weeks thereafter using hyperpolarised 13C-MRI, Clark-type electrodes and biochemical analysis.
Results: Metformin increased renal blood flow, but did not change total kidney oxygen consumption. In healthy rat kidneys, metformin increased [1-13C]lactate production and reduced mitochondrial [1-13C]pyruvate oxidation (decreased the 13C-bicarbonate/[1-13C]pyruvate ratio) within 30 min of administration. Corresponding alterations to indices of mitochondrial, cytosolic and whole-cell redox potential were observed. Pyruvate oxidation was maintained in the diabetic rats, suggesting that the diabetic state abrogates metabolic reprogramming caused by metformin.
Conclusions/interpretation: This study demonstrates that metformin-induced acute metabolic alterations in healthy kidneys favoured anaerobic metabolism at the expense of aerobic metabolism. The results suggest that metformin directly alters the renal redox state, with elevated renal cytosolic redox states as well as decreased mitochondrial redox state. These findings suggest redox biology as a novel target to eliminate the renal complications associated with metformin treatment in individuals with impaired renal function.
Keywords: Diabetes; Hyperpolarised MRI; Metformin; Renal function; Renal metabolism; Renal redox.
Similar articles
-
Hyperpolarised 13C-MRI metabolic and functional imaging: an emerging renal MR diagnostic modality.MAGMA. 2020 Feb;33(1):23-32. doi: 10.1007/s10334-019-00801-y. Epub 2019 Nov 28. MAGMA. 2020. PMID: 31782036 Review.
-
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo.Nat Med. 2018 Sep;24(9):1384-1394. doi: 10.1038/s41591-018-0125-4. Epub 2018 Jul 23. Nat Med. 2018. PMID: 30038219 Free PMC article.
-
Assessment of Metformin-Induced Changes in Cardiac and Hepatic Redox State Using Hyperpolarized[1-13C]Pyruvate.Diabetes. 2016 Dec;65(12):3544-3551. doi: 10.2337/db16-0804. Epub 2016 Aug 25. Diabetes. 2016. PMID: 27561726
-
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.Nature. 2014 Jun 26;510(7506):542-6. doi: 10.1038/nature13270. Epub 2014 May 21. Nature. 2014. PMID: 24847880 Free PMC article.
-
The Redox Communication Network as a Regulator of Metabolism.Front Physiol. 2020 Oct 15;11:567796. doi: 10.3389/fphys.2020.567796. eCollection 2020. Front Physiol. 2020. PMID: 33178037 Free PMC article. Review.
Cited by
-
Hyperpolarised 13C-MRI metabolic and functional imaging: an emerging renal MR diagnostic modality.MAGMA. 2020 Feb;33(1):23-32. doi: 10.1007/s10334-019-00801-y. Epub 2019 Nov 28. MAGMA. 2020. PMID: 31782036 Review.
-
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo.Nat Med. 2018 Sep;24(9):1384-1394. doi: 10.1038/s41591-018-0125-4. Epub 2018 Jul 23. Nat Med. 2018. PMID: 30038219 Free PMC article.
-
Increasing metformin concentrations and its excretion in both rat and porcine ex vivo normothermic kidney perfusion model.BMJ Open Diabetes Res Care. 2020 Aug;8(1):e000816. doi: 10.1136/bmjdrc-2019-000816. BMJ Open Diabetes Res Care. 2020. PMID: 32816871 Free PMC article.
-
Metabolic Action of Metformin.Pharmaceuticals (Basel). 2022 Jun 30;15(7):810. doi: 10.3390/ph15070810. Pharmaceuticals (Basel). 2022. PMID: 35890109 Free PMC article. Review.
-
In Vivo Assessment of Metabolic Abnormality in Alport Syndrome Using Hyperpolarized [1-13C] Pyruvate MR Spectroscopic Imaging.Metabolites. 2021 Apr 6;11(4):222. doi: 10.3390/metabo11040222. Metabolites. 2021. PMID: 33917329 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources